Shree Ganesh Biotech (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Shree Ganesh Biotech (India) Ltd · Outcome · 02 Nov 2026, 10:53 pm
Shree Ganesh Biotech (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 16.0 (-79.2% YoY | -88.8% QoQ) ■ EBITDA: -40.4 (-1.9% YoY | +54.8% QoQ) ■ EBITDA Margin (%): -252 (-20058 bps YoY | -18971 bps QoQ) ■ PAT: -8.1 (Profit to Loss YoY | +85.9% QoQ) ■ EPS (INR): 0.00 (Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Shree Ganesh Biotech (India) Ltd
- PFA · 02 Nov 2026
- PFA · 02 Nov 2026
- Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Pursuant to Regulation .... · 02 Nov 2026
- PFA · 28 Sept 2026
- PFA · 28 Sept 2026
- Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial .... · 03 Sept 2026
- PFA · 03 Sept 2026
- PFA · 01 Sept 2026
